Behcet Syndrome: Clinical Trials

131 trials for Behcet Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

60 completed, 28 unknown, 23 recruiting, 8 not yet recruiting. 28 Phase 2, 21 Not applicable, 13 Phase 3, 6 Phase 1, 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 228Completed 15, Recruiting 4, Terminated 4, Unknown 2, Withdrawn 2, Not yet recruiting 1
Not applicable21Unknown 9, Completed 7, Recruiting 5
Phase 313Completed 7, Recruiting 4, Not yet recruiting 1, Terminated 1
Phase 16Completed 2, Enrolling by invitation 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 44Unknown 2, Active not recruiting 1, Completed 1
Early Phase 11Completed 1

Follow Behcet Syndrome: new trials by email Literature Review of Behcet Syndrome trials Research Report on Behcet Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut
Behçet's Disease
Not yet recruitingAssiut University302026-09-302025-09-05
Serum EBI-3 Protein Levels in Behçet's Disease
Behçet Disease
Not yet recruitingAssiut University902026-09-262026-09-28
Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research
Pericarditis, Tako-TSUBO Cardiomyopathy
Not yet recruitingAssistance Publique - Hôpitaux de Paris3002026-09-012026-08-10
Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym.
Repository Corticotropin Injection (ACTH), Study-matched inactive placebo injection, also called control injection - Behçet's Syndrome, Behçet's Syndrome (BS)
Phase 2Not yet recruitingPeking University People's Hospital602026-09-012026-09-22
Asprosin in Behect Patients
Behcet Disease
Not yet recruitingAssiut University442026-09-012026-09-03
Diet Restiction in Subjects With Behcet Disease and Complaint of Tinnitus
diet restriction - Behcet Disease, Obesity
Not applicableRecruitingCairo University402026-06-042026-07-14
Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease
treadmill walking - Metabolic Syndrome, Behcet Disease
Not applicableRecruitingCairo University402026-06-022026-07-14
Ivarmacitinib for Refractory Behcet's Syndrome
Ivarmacitinib - Behcet's Syndrome
Phase 2WithdrawnLiu Tian2026-06-012026-07-10
Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing
inspiratory muscle trianing - Behcet Disease
Not applicableRecruitingCairo University402026-05-062026-06-23
Clinical, Biochemical and Epigenetic Profile of Pediatric Behçet Disease
Biomarker analysis of blood samples - Behcet Disease and Vascular Involvement
Not applicableRecruitingMeyer Children's Hospital IRCCS902026-01-122026-01-29
EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
observational study - Myocarditis, ANCA Associated Vasculitis
RecruitingAssistance Publique - Hôpitaux de Paris50002025-11-192026-06-05
Cranial Nerve Functions in Behçet's Disease and Their Relationship With Clinical Parameters
Behcet Disease, Cranial Nerve Disorder
Not yet recruitingMarmara University602025-10-012025-08-21
Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls
No intervention (observational study) - Takayasu Arteritis, Behçet's Disease
RecruitingÖZLEM NUR TOK YAMAN302025-09-112025-12-10
Ustekinumab in BEhçet's Syndrome STudy
Behçet's Syndrome (BS)
RecruitingGroupe français d'étude des Maladies Inflammatoires de loeil2082025-09-012025-11-24
Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep Venous Thrombosis of Behçet's Syndrome
Corticosteroids + Rivaroxaban, Corticosteroids alone - Behcet Syndrome
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris1342025-06-242026-04-23
Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease
Placebo plus immunosuppression, Rivaroxaban plus immunosupression - Behcet Disease, Behcet Disease and Vascular Involvement
Phase 3Not yet recruitingMarmara University1102025-04-302025-04-13
Turkish Adaptation of the VascuQoL-6 Quality of Life Scale
Takayasu Arteritis, Behcet Disease
CompletedUşak University372025-03-012025-08-22
Evaluation of Voice in Behcet's
1-Laryngyscopic examination 2-Acoustic analysis - Behcet Disease
Not yet recruitingMinia University602025-02-152025-02-20
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
BCMA-CD19 CAR-T therapy - Systemic Lupus Erythematosus, Inflammatory Myopathy
Phase 2RecruitingPeking University People's Hospital502024-12-262025-04-02
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
RAY121 - Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP)
Phase 1Enrolling by invitationChugai Pharmaceutical1442024-12-092026-07-17

Showing 20 of 131. Sign in to see all of them.

Narrower conditions

Uveitis (17)  ·  Takayasu Arteritis (12)  ·  Giant Cell Arteritis (9)  ·  Granulomatosis with Polyangiitis (8)  ·  Retinal Vasculitis (8)  ·  Sarcoidosis (8)  ·  Arthritis, Juvenile (7)  ·  Arthritis, Rheumatoid (7)  ·  Lupus Erythematosus, Systemic (7)  ·  Microscopic Polyangiitis (7)  ·  Polyarteritis Nodosa (7)  ·  Scleroderma, Systemic (7)  ·  Uveitis, Posterior (7)  ·  Churg-Strauss Syndrome (6)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (131)  ·  Eye Diseases (131)  ·  Genetic Diseases, Inborn (131)  ·  Mouth Diseases (131)  ·  Skin Diseases (131)  ·  Skin Diseases, Genetic (131)  ·  Skin Diseases, Vascular (131)  ·  Skin and Connective Tissue Diseases (131)  ·  Stomatognathic Diseases (131)  ·  Vascular Diseases (131)  ·  Cardiovascular Diseases (130)  ·  Hereditary Autoinflammatory Diseases (130)  ·  Uveal Diseases (130)  ·  Uveitis, Anterior (130)  ·  Panuveitis (128)

Interventions

apremilast (4)  ·  Cyclophosphamide (3)  ·  Quality of Life (3)  ·  tocilizumab (3)  ·  Adrenal Cortex Hormones (2)  ·  Blood Specimen Collection (2)  ·  Butyrates (2)  ·  Colchicine (2)  ·  Cyclic Nucleotide Phosphodiesterases, Type 4 (2)  ·  Cyclosporine (2)  ·  Diet, Vegetarian (2)  ·  Hemay005 (2)  ·  Infliximab (2)  ·  Interferon alpha-2 (2)  ·  Interleukin-2 (2)

Sponsors

Assiut University (17)  ·  Assistance Publique - Hôpitaux de Paris (7)  ·  Tehran University of Medical Sciences (6)  ·  Cairo University (5)  ·  University of South Florida (5)  ·  Amgen (4)  ·  National Eye Institute (NEI) (4)  ·  Peking Union Medical College Hospital (4)  ·  Bursa Yuksek Ihtisas Training and Research Hospital (3)  ·  Gazi University (3)  ·  Liu Tian (3)  ·  Novartis Pharmaceuticals (3)  ·  Ataturk University (2)  ·  Azienda Ospedaliero-Universitaria Careggi (2)  ·  Chugai Pharmaceutical (2)

Countries

Turkey (Türkiye) (29)  ·  United States (26)  ·  China (16)  ·  Egypt (15)  ·  France (14)  ·  Italy (12)  ·  Iran (8)  ·  Germany (7)  ·  Spain (7)  ·  Greece (6)  ·  Israel (4)  ·  Japan (4)  ·  South Korea (4)  ·  Australia (3)  ·  Netherlands (3)

Top investigators

Fereydoun Davatchi, MD (4)  ·  Peter A. Merkel, MD, MPH (4)  ·  Ali MA Ismail, lecturer (3)  ·  Amanda M. Terry, MA (3)  ·  Bahar Sadeghi, MD (3)  ·  Farhad Shahram, MD (2)  ·  Farhad Shahram, Professor (2)  ·  Hormoz Shams, MD (2)  ·  Megan Clowse, MD, MPH (2)  ·  Peter A Merkel, MD, MPH (2)  ·  Peter C. Grayson, MD (2)  ·  Sara Farrag, Lecturer (2)

Results publications

PMID 37316690, PMID 11459787, PMID 15161982, PMID 16998234, PMID 17960403, PMID 19026127, PMID 19597921, PMID 1970380, PMID 19717547, PMID 20704622, PMID 20926833, PMID 21482866, PMID 23290985, PMID 23773637, PMID 24488418, PMID 25638011, PMID 25875256, PMID 26879979, PMID 27310969, PMID 28335798, PMID 28528519, PMID 29471416, PMID 30146446, PMID 30472651, PMID 31722152, PMID 32118582, PMID 32517729, PMID 32814420, PMID 34212234, PMID 34531393, PMID 34596034, PMID 34864108, PMID 3508756, PMID 35413570, PMID 35463015, PMID 35755024, PMID 35798511, PMID 35831701, PMID 35899212, PMID 35935379, PMID 36160138, PMID 36578194, PMID 36881285, PMID 37435280, PMID 37517110, PMID 38206518, PMID 38782788, PMID 38825350, PMID 38825354, PMID 39915014

NIH funding

2023 (2), 2009 (1), 2014 (1), R21EY036563 (1)